STUDY DESIGN AND METHODS:
A murine model of self-limited peritonitis was used, and resolution was assessed by resolution indices. Western blot, quantitative reverse transcriptase polymerase chain reaction, chemotaxis assay, luciferase reporter assay, and lentivirus infections were used to investigate possible mediating mechanisms in neutrophils.
RESULTS:
The administration of hemin by intraperitoneal injection significantly increased the leukocyte infiltration and prolonged the resolution interval by approximately 7 hours in mouse peritonitis. In vitro, hemin significantly downregulated ALX/FPR2 protein levels (p < 0.05), a key resolution receptor, leading to the suppression of proresolution responses triggered by the proresolution ligand resolvin D1. Subsequently, miR-144-3p, selected by prediction databases, was found to be significantly upregulated by hemin (p < 0.05). The inhibition of miR-144-3p attenuated the inhibitory effect of hemin on lipoxin A 4 receptor (ALX)/formyl peptide receptor 2 (FPR2) protein expression (p < 0.05). Luciferase reporter assay confirmed that miR-144-3p directly bound ALX/FPR2 3 0 -UTR. MiR-144-3p overexpression significantly downregulated ALX/FPR2 protein levels, whereas miR-144-3p inhibition led to a significant increase in ALX/FPR2 (p < 0.05).
CONCLUSION:
Our results suggest that hemin prolongs resolution in self-limited inflammation, and this action is associated with downregulation of ALX/FPR2 mediated by hemin-induced miR-144-3p. These findings demonstrate a novel mechanism of hemin derived from stored RBCs for inflammatory response.
A cute inflammation is a protective response for the body to maintain homeostasis, preventing host damage. It is a self-limiting process, and a key step is the active resolution phase. Overly aggressive or prolonged inflammation, which fails to resolve, can lead to tissue damage. 1 At the cellular level, the key events in resolution are inhibition of neutrophil (polymorphonuclear neutrophil [PMN] ) recruitment and clearance of apoptotic cells through efferocytosis of macrophages. 2 Lipoxin A 4 receptor (ALX)/formyl peptide receptor 2 (FPR2) acted as a pivotal checkpoint in host defense, inhibited the recruitment of PMNs into the inflamed site, and promoted PMN apoptosis by recognizing proresolving mediators, such as lipoxin A 4 , 3 resolvin D1 (RvD1), 4 and annexin A1. 5 A more recent work suggests that neutrophils expressing ALX/FPR2 play a key role in the resolution of inflammation and immune regulation. 6, 7 Dufton et al. 8 found that the inhibition of PMN recruitment by annexin A1 was attenuated largely in Fpr2 −/− (the murine homologue of ALX/FPR2) mice, leading to greater acute inflammation and a prolongation of inflammatory arthritis. Blocking neutrophil Fpr2 and knocking out Fpr2 result in increased cerebral damage and systemic inflammation following ischemia reperfusion, while Fpr2 agonists attenuate ischemia reperfusioninduced cerebrovascular injury and inflammatory response. 9 Thus, the levels of ALX/FPR2 are closely associated with host defense, immune regulation, and the resolution of inflammation. 10, 11 Heme derived from hemolysis is a dangerous molecule because of its cytotoxicity and proinflammatory action. 12 Besides sickle cell disease, malaria, and sepsis, concentrations of hemin were found to increase up to about 50 μmol/L after 28 to 30 days of storage in stored packs of RBCs, which undergo numerous biochemical and biomechanical changes. 13 Transfusion of stored RBCs also results in increased plasma hemin levels. 14 Clinical reports have demonstrated that poor clinical outcomes, for example, acute lung injury, multiple organ failure, infection, and mortality, are related to transfusion of stored RBCs in certain groups of patients, including trauma, intensive care, and cardiac surgery patients. [15] [16] [17] [18] Experimental studies suggest that transfusion of long-stored RBCs produced higher mortality rates and diffuse tissue inflammation compared to transfusion of fresh RBCs in a murine model of hemorrhagic shock. However, removing hemin from plasma and antihemin therapies reversed these effects. 14, 19 Previous studies also reported that hemin can stimulate neutrophils to release neutrophil extracellular traps, which contributed to the onset of transfusion-related acute lung injury and the pathogenesis of sickle cell disease. 20, 21 With respect to the mechanisms, it has been demonstrated that hemin not only directly promotes lipid peroxidation but also promotes oxidative damage and inflammation through triggering tolllike receptor 4, and activating selective signaling pathways. 12 In addition, hemin can activate neutrophils through mechanisms of protein kinase C activation and reactive oxygen species generation, inducing the production of chemokines. 22 However, whether hemin can influence the resolution of inflammation through regulating ALX/FPR2 expression, the key step of acute inflammation, remains to be determined. This may be a new mechanism by which hemin aggravates inflammation. MicroRNAs (miRNAs) are known to regulate several gene targets, which have important roles in acute inflammation and resolution. 23 Recent studies have found that miRNAs regulated by RvD1, e.g., miR-146b and miR-21, are involved in regulating self-limited inflammation. 24 In addition, Li et al. 25 found that miR-466I plays a pivotal role in dynamic leukocyte plasticity during resolution of acute inflammatory responses. Moreover, RvD1-induced miR-21 can limit inflammation and promote resolution by targeting the tumor suppressor programmed cell death 4 protein gene. 26 Hence, finding out whether hemin influences the resolution of inflammation through relative miRNAs is of considerable interest. Importantly, Pierdomenico et al. 27 found that miR-181b modulates pro-resolution signals in macrophages by directly down regulating ALX/FPR2
expression. Thus, we hypothesize that hemin can regulate resolution via miRNA-dependent down regulation of ALX/FPR2. In this study we provide evidences that hemin prolongs resolution of inflammation in self-limited experimental mouse peritonitis induced by zymosan, which is related to down regulation of ALX/FPR2 mediated by hemin-induced miR-144-3p in neutrophils. It may provide new therapeutic targets for diseases that have hemin release, including stored RBCs transfusion-associated complications.
MATERIALS AND METHODS

Materials
Zymosan A, hemin, and dimethyl sulfoxide (DMSO) were purchased from Sigma-Aldrich, RvD1 was purchased from Cayman Chemical.
Murine peritonitis
Male C57BL/6 J mice (6-8 weeks old) were administered zymosan A (50 mg/kg) in 1 mL of sterile saline alone and with hemin (5 mg/kg) by intraperitoneal (IP) injection. At selected time intervals, the mice were euthanized, and peritoneal exudates were collected by lavaging with Ca 2+ /Mg 2+ -free Dulbecco's phosphate-buffered saline (5 mL). Lavages and murine serum were collected for enzyme-linked immunosorbent assay (ELISA). Leukocytes in the peritoneal exudates were counted using a hemocytometer and differential cell counts were assessed with flow cytometry. Fluorescein isothiocyanate-conjugated anti-mouse Ly-6G/Ly-6C (Gr-1) (BioLegend) and antigen-presenting cell-conjugated antimouse F4/80 antibodies (eBioscience) were used for flow cytometry. Isotype-matched mouse immunoglobulin served as controls. Differential cell numbers were used to determine resolution indices. 23, 28, 29 T max is the time point of maximum PMN infiltration in the exudates. T 50 is the time point at which PMN numbers reach half of the maximum PMN numbers. Resolution interval (R i ) is the time interval between T max and T 50 (R i = T 50 -T max ). All procedures used in this study were approved by the Institutional Animal Care and Use Committee of the Third Military Medical University.
Isolation of human neutrophils
Neutrophils were isolated from human peripheral blood of healthy adults by gradient centrifugation using isolation kits (tbdscience). Briefly, peripheral blood was added gently into the isolation buffer and centrifuged (800g, 25 min). Neutrophils were separated from buffy coats. RBCs were lysed with RBCs lysis buffer, and then neutrophils were washed three times with wash buffer (350g, 5 min). The cells were resuspended in a cell culture medium (RPMI 1640, Hyclone) with 10% fetal bovine serum (FBS) and counted. This procedure yielded greater than 95% neutrophil purity and greater than 95% viability as assessed by flow cytometry (FACS Canto II, Becton Dickinson) and trypan blue staining.
HL-60 cell culture and differentiation
The cell line HL-60 was purchased from the Culture Collection of Chinese Academy of Sciences. HL-60 cells were cultured in Iscove's Modified Dulbecco's Medium (Hyclone) with 20% FBS combined with 1% penicillin/streptomycin and 1% glutamine at 37 C/5% CO 2 . Differentiation was induced in the cells by the addition of 1.3% DMSO for 6 days (dHL-60).
The percentage of CD11b-positive cells was greater than 90% when HL-60 cells were induced for 6 days. The DMSOinduced HL-60 is an approved model to study the biological function of neutrophils as previous articles show. 30, 31 In silico analysis
Two databases, namely, TargetScanHuman and microRNA.org, were used to predict the binding of human miRNA to ALX/FPR2 3 0 -UTR. A context++ score percentile of 90 or greater in TargetScanHuman is taken as the cutoff value for prediction of miRNA potential binding site. 32 MirSVR scores served as another prediction parameter in microRNA.org; the lower the value, the stronger the stability of miRNA-mRNA binding. were measured with a dual-luciferase reagent assay kit (Promega). All reporter assays are shown as relative luciferase activities, and firefly luciferase is used as internal reference.
Lentiviral transduction
Lentivirus with has-miR-144-3p precursor sequence and reverse complementary sequence of has-miR-144-3p (Genechem) were transfected into dHL-60 cells to overexpress and inhibit miR-144-3p, respectively. Lentivirus with relative vectors were used as the negative control. dHL-60 cells were seeded onto a 24-well culture plate at 2 × 10 5 / well. Lentivector supernatants (Lenti-miR-144-3p, Lenticontrol, Anti-miR-144-3p, and Anti-control) were added to the cells at a multiplicity of infection (MOI) of 50 in the presence of polybrene (5 μg/mL). After 12 hours of culture, the supernatant was replaced with a fresh medium. The expression of green fluorescent protein was analyzed using a fluorescence inverted microscope (Olympus) after 5 days. Subsequently, positive clones were selected with 3 μg/mL puromycin. The levels of miR-144-3p in stable clones were verified by qRT-PCR.
RNA extraction and real-time PCR
Total RNA was extracted from cultured cells using an RNA extraction solution (Trizol, Invitrogen). A reagent kit (PrimeScript RT, TaKaRa) was used for reverse transcriptions for mRNAs and miRNAs, and miRNA-specific stemloop RT primers (RiboBio) were used for the synthesis of miRNAs cDNA. Thereafter, real-time reverse transcription PCR was carried out using a kit (SsoFast EvaGreen Supermix, BioRad) with the Bio-Rad CFX Connect real-time PCR system. The relative expression levels of mRNAs and miRNAs were normalized to that of internal control β-actin and U6, respectively, by using the 2 -ΔΔCt cycle threshold method.
Western blot
Forty micrograms of total protein was loaded in sodium dodecyl sulfate-polyacrylamide gel electrophoresis and then transferred to polyvinylidene fluoride microporous membranes (Millipor). After blocking using 5% nonfat dry milk, the membranes were incubated with the primary antibodies overnight at 4 C. The following antibodies were used in this study: polyclonal antibody ALX/FPR2 (1:1000; GeneTex) and monoclonal antibody glyceraldehyde 3-phosphate dehydrogenase (1:1000; Santa Cruz Biotechnology). Subsequently, the membranes were incubated with horseradish peroxidase-conjugated antirabbit or anti-mouse IgG secondary antibody (1:5000, Santa Cruz Biotechnology) for 2 hours at room temperature. Immunoreactive signals were detected by incubating with a chemiluminescence plus reagents (Millipore). The protein bands were visualized using an imager (ChemiDoc MP Bio-Rad), and band intensities were quantified using computer software (Image Lab 5.2, Bio-Rad). Glyceraldehyde 3-phosphate dehydrogenase was used for protein normalization.
Flow cytometry
Leukocytes from mice peritoneal cavity were washed in Dulbecco's phosphate-buffered saline with 1% FBS, and 1 × 10 6 cells were incubated with rabbit anti-ALX/FPR2
antibody (Abcam) for 1 hour at room temperature. After three washes, cells were stained with phycoerythrinconjugated anti-rabbit IgG secondary antibody (BioLegend) for 30 minutes in the dark. The cells were washed again with staining buffer and stained with fluorescein isothiocyanate-conjugated anti-mouse Ly-6G/Ly-6C (Gr-1) and antigen-presenting cell-conjugated anti-mouse F4/80 antibodies in the dark for 15 minutes at room temperature. After a further wash, cells were washed twice with staining buffer and analyzed immediately by flow cytometry (FACS Canto II, BD Biosciences). ALX/FPR2 expression in human neutrophils and dHL-60 cells after treatment with hemin were also evaluated by the above-mentioned method.
Enzyme-linked immunosorbent assay
Human neutrophils were exposed to hemin alone and also combined with different concentrations of RvD1 for 4 hours at 37 C/5% CO 2 . TNF-α and IL-6 levels in culture supernatants, murine serum, and peritoneal lavages were detected using ELISA kits (NeoBioscience) according to the manufacturer's instructions.
Chemotaxis assay
The chemotaxis assay was performed in a transwell chamber (Corning) with a 3-μm porous membrane. Human neutrophils or dHL-60 cells (1-1.5 × 10 6 /500 μL) were added to the upper chamber and allowed to migrate toward the lower chamber with hemin alone and also combined with different concentrations of RvD1 for 4 hours at 37 C/5% CO 2 . Migrated cells collected from the lower chamber were centrifuged (1200 rpm, 5 min) and counted using a hemocytometer.
Statistical analysis
All data were expressed as mean AE standard deviation unless otherwise indicated. Statistical analysis was performed using the double-sided Student t test or one-way analysis of variance by statistical analysis software (SPSS 16.0, SPSS Inc.). A p value of less than 0.05 was considered a significant difference.
RESULTS
Hemin prolongs resolution and aggravates inflammation in vivo
To determine whether hemin influences inflammation resolution, we used a mouse model of self-limited peritonitis initiated by zymosan A (50 mg/Kg). Zymosan A and zymosan A plus hemin (5 mg/kg) were administered by IP injection, and peritoneal lavages were collected at 4, 12, 24, and 48 hours to monitor temporal changes in the leukocyte composition. (Fig. 1A) . Differential analysis with flow cytometry found that the majority of extravasated lekocytes at 4 hours and 12 hours were Gr-1 high / F4/80 − PMN, which was followed by a steady decline at the resolution phase (24-48 h) (Fig. 1B,D) . PMN number values were used to calculate resolution indices as described in Materials and Methods. The administration of hemin significantly increased the PMN infiltration at 4 hours (26.3 AE 0.4 × 10 6 cells vs. 5.1 AE 0.5 × 10 6 cells), and increased ψ max from 26.5 AE 1.3 × 10 6 to 27.9 AE 3.0 × 10 6 cells at 12 hours. Notably, hemin markedly prolonged resolution by increasing the R i by about 7 hours, from 14 hours to 21 hours (Fig. 1B) . Furthermore, the percent of macrophages in extravasated lekocytes were decreased at 24 hours and 48 hours after hemin challenge (Fig. 1C) . The administration of hemin significantly enhanced the expression of TNF-α and IL-6 in peritoneal lavages and murine serum at 4 hours (Fig. 1E,F) , 12 hours and 24 hours (Fig. 1G,H) , respectively. Together, these results indicate that hemin prolongs resolution and aggravates acute inflammation in mouse peritonitis.
Down regulation of ALX/FPR2 induced by hemin affects resolution action of RvD1 in hemintreatment neutrophils
It is well known that ALX/FPR2 play key roles in resolution through interacting with pro-resolving ligands, inhibiting recruitment of PMN, promoting PMN apoptosis and mediating the production of inflammatory factors. To determine if prolonged resolution by hemin is related to ALX/FPR2 expression, we treated human neutrophils with hemin in vitro and detected inflammatory responses of human neutrophils exposed to ALX/FPR2 agonist RvD1. As shown in Fig. 2 , western blot ( Fig. 2A ) and flow cytometry (Fig. 2B ) analysis both demonstrated that hemin (15 μM, 20 μM) significantly down regulated the protein expression of ALX/FPR2 when neutrophils were treated with increasing concentrations of hemin (5 μM, 10 μM, 15 μM, 20 μM) (p < 0.05). Furthermore, these results were also confirmed in dHL-60 cells (Fig. 2C,D) . Finally, 15 μM was the working concentration of hemin in our study in consideration of the results in neutrophils. However, compared with the control group, the mRNA level of ALX/FPR2 had no significant change in both hemin-treated neutrophils and dHL-60 cells (Fig. 2E,F) , indicating that hemin may posttranscriptionally regulate the expression of ALX/FPR2. To further determine if hemin-induced down regulation of ALX/FPR2 had an impact on pro-resolution action of RvD1, neutrophils and dHL-60 cells treated with hemin were exposed to increasing concentrations of RvD1 (1 nM, 10 nM, 100 nM). As shown in Fig. 3 , hemin significantly promoted the chemotaxis of neutrophils (Fig. 3A) and dHL-60 cells (Fig. 3B) (p < 0.05), which is consistent with the findings of previous studies. 34 However, the antimigratory action of RvD1 was not observed in both neutrophils and dHL-60 cells in the presence of hemin, even if the concentration of RvD1 is as high as 100 nM. Furthermore, we also examined the secretion of TNF-α by ELISA. Hemin significantly increased TNF-α release (p < 0.05), but increasing concentrations of RvD1 did not did not reduce TNF-α release in both hemintreated neutrophils and dHL-60 cells (Fig. 3C,D) . These results indicate that down regulation of ALX/FPR2 expression by hemin is associated with the suppression of proresolution responses triggered by RvD1 in neutrophils.
Selection of microRNAs that putatively bind to ALX/FPR2 3 0 -UTR
We investigated the mechanism of down regulation of ALX/FPR2 expression induced by hemin. A previous study had confirmed that miR-181b can control ALX/FPR2 expression and modulate pro-resolution signals in macrophages. 27 In the present study, we found that hemin may posttranscriptionally
Volume 59, January 2019 TRANSFUSION 199 regulate the expression of ALX/FPR2, and that miRNAs are important modulators of gene expression in a similar way to posttranscriptional regulation. Thus, we hypothesize that the mechanism by which hemin down regulates the expression of ALX/FPR2 is related to microRNAs. To confirm the hypothesis, we first identify miRNAs that will most likely bind to ALX/FPR2 3 0 -UTR through two prediction databases, TargetScanHuman and microRNA.org. Twenty-five miRNAs predicted by both algorithms to bind to the 3 0 -UTR of ALX/FPR2 were further selected based on context++ score percentile and mirSVR scores as described in Materials and Methods (Fig. 4A) . Four predicted miRNAs (miR-543, miR-144-3p, miR-181b-3p, and miR-410-3p) that will most likely bind to ALX/FPR2 3 0 -UTR were identified (Fig. 4B) .
Hemin up regulates miR-144-3p expression in neutrophils
We further investigated the effects of hemin on the expression of the identified miRNAs in the neutrophils. qRT-PCR was performed to detect changes in miRNAs expression in hemin-treated neutrophils. As shown in Fig. 5A , compared with the control group, hemin significantly up regulated miR-144-3p expression (p < 0.05) but not the other three miRNAs. A similar result was observed in dHL-60 cells. The expression of miR-144-3p in hemin-treated dHL-60 cells was markedly increased after treatment for 12 hours (p < 0.05) and 24 hours (p < 0.01), respectively (Fig. 5B) . These results provide underlying evidence that hemin may control ALX/FPR2 expression by miR-144-3p.
Hemin-regulated ALX/FPR2 expression is dependent on miR-144-3p
Given that hemin significantly down regulated the levels of ALX/FPR2 protein and up regulated miR-144-3p, we next sought to determine if hemin could down regulate ALX/FPR2 expression via miR-144-3p. dHL-60 cells were infected with lentivirus with reverse complementary sequence of miR-144-3p (Anti-miR-144-3p) and vector (Anti-con). The levels of miR-144-3p in stable transfected cells were detected by qRT-PCR (data not shown), and then the transfected dHL-60 cells were treated with hemin. We found that the inhibition of miR-144-3p significantly attenuated the inhibitory effect of hemin on ALX/FPR2 protein expression (p < 0.05; Fig. 6 ), suggesting that the down regulation of ALX/FPR2 induced by hemin is dependent on miR-144-3p. We next determined the effect of miR-144-3p on ALX/FPR2 protein expression. Compared with the negative control group, infection with lentivirus with miR-144-3p precursor sequence (Lenti-miR-144-3p) significantly increased miR-144-3p levels in dHL-60 cells and resulted in significant reduction of ALX/FPR2 protein levels (p < 0.05, Fig. 7B ). However, in dHL-60 cells infected with lentivirus with reverse complementary sequence of miR-144-3p (Anti-miR-144-3p), the levels of miR-144-3p were markedly decreased (p < 0.05), and ALX/FPR2 protein levels were significantly increased (p < 0.01; Fig. 7C ). Together, these data demonstrate that ALX/FPR2 is a direct target gene of miR-144-3p.
MiR-144-3p directly targets the 3
DISCUSSION
In the present study, we found that hemin prolonged resolution in self-limited inflammation, and this action is related to the down regulation of ALX/FPR2 mediated by hemininduced miR-144-3p. Despite the fact that many studies have demonstrated the effects of hemin and its mechanisms from the point of proinflammation, our findings indicate that hemin regulates ALX/FPR2 expression via miRNA, as a new underlying mechanism, to control the duration of inflammation and prolong resolution. Heme consists of a tetrapyrrole ring with an iron atom bound in the center; it is a dangerous molecule once released from heme proteins because of its pro-oxidant, cytotoxic, and inflammatory effects. 11 Besides sepsis, malaria, and sickle cell disease, the level of hemin is significantly increased in both stored mouse and human RBCs, implying its potential role in storage-related toxicities.
14,21
Graw et al. 14 found that transfusion of stored RBCs in a mouse hemorrhagic shock model resulted in greater plasma hemin levels, organ damage, tissue inflammation, and higher mortality rates compared with transfusion of fresh RBCs. However, binding hemin to hemopexin reversed these effects. 12 Consistent with these findings, Stapley et al. 19 also reported that anti-hemin strategies significantly protected against stored RBCs' toxicity in a mouse traumahemorrhage model. Thus, understanding the molecular mechanism by which hemin acts may contribute to the development of a new therapy for diseases that have hemin release. It is well known that inflammation is a complex process and impaired or prolonged resolution may cause chronic inflammation and tissue damage. Notably, almost all previous studies focused on the proinflammatory capacity of hemin. However, it is unclear whether hemin has an effect on resolution, which can result in a persistent inflammatory response. In the present study, we employed a mouse model of self-limited inflammation and found that hemin significantly increased the leukocyte infiltration in peritoneal exudates and enhanced the expression of TNF-α and IL-6, as well as increased the resolution interval (R i ) by about 7 hours (Fig. 1) . These results suggest that hemin prolongs resolution and aggravates acute inflammation in the mouse peritonitis. This may be a new mechanism to understand the effects of hemin on inflammatory response. To evaluate the mechanisms of hemin, we focused on ALX/FPR2, which acts as a pivotal checkpoint in acute host defense and transduces anti-inflammatory signals by recognizing anti-inflammatory ligands, for example, lipoxin A 4 , annexin A1, and RvD1. This receptor is expressed in a variety of cell types, such as endothelial cells, neutrophils, and macrophages. 35 Much is known about the proinflammatory functions of neutrophils; however, a more recent work suggests that neutrophils expressing ALX/FPR2 play a key role in host defense and resolution of inflammation. 7, 9 Here, we hypothesize that hemin can regulate ALX/FPR2 expression, resulting in impairment of neutrophils pro-resolution responses triggered by ALX/FPR2 agonist. As expected, we found that hemin significantly down regulated the expression of ALX/FPR2 in human neutrophils and dHL-60 cells (Fig. 2) . Furthermore, we observed that hemin significantly promoted chemotaxis of neutrophils and increased TNF-α release. However, inhibition of migration and decrease in TNF-α were not observed in hemin-treated neutrophils when exposed to ALX/FPR2 agonist RvD1 (Fig. 3) , even if the concentration of RvD1 is as high as 100 nM. This means that the pro-resolution responses triggered by RvD1 were affected by hemin. These findings are similar to the results published by Norling et al. 4 They found that the inhibitory actions of RvD1 (10 nM) on PMN recruitment were significantly attenuated when cells were preincubated with anti-ALX/FPR2 and that the anti-inflammatory actions of RvD1 were abolished in the absence of fpr2 in vivo. Therefore, the suppression of pro-resolution responses triggered by RvD1 in neutrophils is associated with the down regulation of ALX/FPR2 expression mediated by hemin, although additional mechanisms cannot be excluded. Of course, this interesting result should be further confirmed in other cells such as macrophages. Next, we investigated the mechanism by which hemin down regulates ALX/FPR2 in neutrophils. A series of studies have revealed that miRNAs have important roles in acute inflammation and resolution. 23, 24 We found that hemin significantly down regulated the protein levels of ALX/FPR2 but not the mRNA levels (Fig. 2) , suggesting that hemin may posttranscriptionally regulate the expression of ALX/FPR2. Thus, we hypothesize that the mechanism by which hemin down regulates the expression of ALX/FPR2 is related to miRNAs. To test this hypothesis, we used two miRNA target prediction tools, TargetScan and microRNA.org, to predict miRNAs that will most likely bind to ALX/FPR2 3 0 -UTR based on context++ score percentile and mirSVR scores as described in Materials and Methods. Four predicted miRNAs were identified, but only miR-144-3p was significantly up regulated in hemintreated neutrophils and dHL-60 cells (Fig. 5) . Furthermore, the inhibition of miR-144-3p significantly attenuated the inhibitory effect of hemin on ALX/FPR2 protein expression in dHL-60 cells (Fig. 6 ), suggesting that miR-144-3p is involved in the down regulation of ALX/FPR2 induced by hemin. miR-144 has been characterized as a "common miRNA signature" of many different types of tumors in humans. 36 Besides its involvement in cancer, miR-144-3p has been linked to inflammatory response. Hu et al. 37 reported that miR-144-3p promoted proinflammatory cytokine production, including TNF-α, IL-1β, and IL-6, and played critical roles in the pathophysiological processes of acute myocardial infarction. However, Li et al. 38 found that miR-144 negatively regulated toll-like receptor 2 expression and decreased the activation of NF-κB and the production of its downstream proinflammatory cytokines (TNF-α and IFN-γ) in vitro. This opposite function of miR-144 may be related to different disease models. In our study, we found that ALX/FPR2, a key receptor for the resolution of inflammation, was the target gene of miR-144-3p, thus regulating ALX/FPR2 protein expression in dHL-60 cells (Fig. 7) . Thus, it is likely that hemin increased the levels of miR-144-3p, which resulted in the down regulation of ALX/FPR2 protein, suppressing proresolution responses triggered by RvD1 in neutrophils. Of course, other predicted miRNAs may regulate ALX/FPR2 expression. This should be investigated in future studies. Taken together, our experiments show that hemin could prolong resolution of inflammation in self-limited inflammation; the mechanism is related to the down regulation of ALX/FPR2 by hemin-induced miR-144-3p. These results not only demonstrate the underlying mechanisms of hemin derived from stored RBCs in inflammatory response but also identify a novel regulatory mechanism of ALX/FPR2 * p < 0.05 versus Anti-con; † P < 0.05 versus Anti-con + hemin.
protein expression, which may be useful for further related researches and contribute to the development of a new therapy for diseases that have hemin release, including stored RBCs transfusion-associated complications. 
